Piperine doubles CBD absorption when taken by mouth

Researchers investigated a promising strategy to improve how the body absorbs CBD (cannabidiol) when taken by mouth. By combining CBD with piperine—a compound found in black pepper—and encapsulating both in tiny fat-based carriers called nanostructured lipid carriers (NLCs), scientists discovered they could double the amount of CBD that enters the bloodstream. The study compared different formulation approaches, finding that CBD isolate performed significantly better than CBD extract when paired with piperine.

The research employed sophisticated laboratory digestion models and real-world animal studies to understand how piperine works alongside CBD. Critically, the form of CBD mattered: NLC capsules containing CBD isolate and piperine showed 87% bioaccessibility in digestion tests, while the same formulation with CBD extract yielded only 13%. When tested in mice, the piperine-enhanced formulation delivered twice the systemic CBD exposure compared to CBD alone in hemp seed oil, establishing clear proof that codelivery with piperine is an effective absorption booster.

This discovery has important practical implications for CBD users who struggle with inconsistent effects or require higher doses. By utilizing piperine as a bioavailability enhancer, manufacturers could create CBD products that deliver more active compound at lower doses, potentially reducing costs and improving therapeutic effectiveness. The findings suggest that formulation strategy—not just the CBD amount—plays a crucial role in determining whether oral CBD actually reaches the body's systems in meaningful quantities.